NURS FPX 8006 Assessment 2 Appraising the Evidence With One Instrument example

Reviewed by Odette Lachlan, MSN, RN Nursing Research and Evidence-Based Practice Capella University Free custom sample in 24 to 48h

This NURS FPX 8006 Assessment 2 sample paper appraises the evidence with one instrument for daily chlorhexidine bathing to reduce hospital-acquired infections. It belongs to Capella NURS FPX 8006, the DNP research course that students register for as NURS-FPX8006. The paper applies one appraisal instrument evenly to every study, presents the studies in a table, and keeps level of evidence separate from quality. It names specific threats rather than categories, criticizes supportive studies as closely as others, traces conflicting findings to their causes and notes what the trials did not measure. A synthesis, implications for practice and the limitations of the appraisal close it.

CourseNURS FPX 8006 Nursing Research and Evidence-Based Practice
AssessmentAssessment 2
Paper typeEvidence appraisal paper
LengthAbout 1,080 words, 5 pages
FormatAPA 7 student paper
SchoolCapella University
ProgramDNP
UpdatedSeptember 2026

Free sample paper for NURS FPX 8006 Assessment 2

1

Appraising the Evidence With One Instrument: Daily Chlorhexidine Bathing to Reduce Hospital-Acquired Infections

Student Name

Capella University

NURS FPX 8006: Nursing Research and Evidence-Based Practice

Instructor Name

Month Day, Year

What this part is doingThe title names the intervention, the outcome, and the discipline of using one instrument. An appraisal is judged on consistency, so the instrument is part of the promise.
2

Introduction

Chlorhexidine bathing, in which patients are washed daily with cloths containing chlorhexidine gluconate rather than soap and water, is used in many intensive care units to reduce bloodstream infections and colonization with resistant organisms. Its use has spread to general medical and surgical units, raising the question of whether the evidence supports it there. This paper appraises key studies using a single instrument, separates the level of evidence from its quality, names specific threats to validity, criticizes studies that support the practice as well as those that do not, and traces conflicts between findings.

One Instrument, Applied Evenly

Each study was appraised with the Johns Hopkins evidence-based practice model's research appraisal tool, which rates evidence level, from Level I for randomized trials and systematic reviews of trials to Level III for nonexperimental studies, and separately rates quality as high, good, or low based on consistency, sample size, control of bias, and generalizability (Dang et al., 2022). Using one instrument for every study prevents the common error of scrutinizing studies that disagree with a preferred conclusion more harshly than those that agree with it.

The Studies Appraised

Three studies form the core of the evidence. The first is a multicenter cluster randomized crossover trial conducted in critical care units and hematopoietic stem cell transplant units, in which daily chlorhexidine bathing reduced acquisition of resistant organisms and hospital-acquired bloodstream infections compared with nonantimicrobial washcloths (Climo et al., 2013). The second, a pragmatic crossover trial run across the adult ICUs of one university hospital, in which chlorhexidine bathing did not reduce a composite of central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and Clostridioides difficile infections (Noto et al., 2015). The third is a large cluster randomized trial of decolonization strategies in non-critical-care units, which found that universal chlorhexidine bathing with nasal decolonization did not significantly reduce multidrug-resistant organism cultures overall, although a benefit appeared among patients with medical devices (Huang et al., 2019).

Level and Quality Kept Apart

Level and quality answer different questions. The first two trials are both Level I, because both are randomized. Their quality differs. The first trial had a larger number of units, a clear primary outcome, and consistent effects, which supports a rating of high quality. The second trial had a pragmatic design in a single institution with a composite outcome and relatively low baseline infection rates, which supports a rating of good quality with limits on generalizability. Treating both as equally strong because they share a level would obscure important differences.

What this part is doingThe appraisal separates the design level from the quality of execution for each study. Scorers reward appraisals that avoid treating all randomized trials as equally strong.
3

Named Threats, Not Categories

Threats to validity are named specifically. In the supportive trial, the washcloths used in the control arm differed in appearance from the chlorhexidine cloths, so staff knew which period their unit was in, which could have influenced other infection prevention behaviors during the chlorhexidine period. Adherence to bathing was measured incompletely. In the null trial, the composite outcome combined infections with different causes, some of which, such as ventilator-associated pneumonia, chlorhexidine skin bathing would not be expected to prevent, diluting any effect on bloodstream infections. The low baseline rate of bloodstream infections limited the trial's power to detect a difference.

Supportive Studies Criticized Too

Criticizing only the null trial would be unbalanced. The supportive trial was conducted in units with high baseline infection rates, including bone marrow transplant units, where the benefit may be larger than in typical units. Some participating units had other infection prevention initiatives under way. The supportive trial is strong evidence that chlorhexidine bathing helps in high-risk intensive care settings, but it does not show that the benefit extends to general wards.

Conflicts Traced to Causes

The trials appear to conflict, but tracing the differences explains much of the conflict. The trials differ in population, since high-risk intensive care and transplant units are not the same as a general mixed intensive care unit or medical wards; in outcome, since bloodstream infections are more directly related to skin colonization than a composite of infections; and in baseline rates, since interventions show larger effects where infections are more common. Read together, the trials suggest that chlorhexidine bathing reduces bloodstream infections and colonization in high-risk units, with less clear benefit in lower-risk populations.

What the Trials Did Not Measure

The appraisal also found gaps that no study addressed. None of the three trials measured patient experience, although some patients find chlorhexidine cloths uncomfortable or drying. Few reported skin reactions systematically. None was designed to detect emerging resistance to chlorhexidine over time, which laboratory studies have raised as a concern. And none compared the cost of chlorhexidine bathing with the cost of the infections it prevents in a general ward population. Naming what the evidence does not cover keeps the synthesis from implying a completeness the trials do not have.

What this part is doingThe appraisal identifies gaps across the whole body of evidence, not only within each study. Scorers reward appraisals that read the literature as a set.
4

Synthesis

Taken as a whole, the evidence supports daily chlorhexidine bathing in intensive care units, particularly those with high baseline rates of bloodstream infection or resistant organisms, and in patients with central lines. The evidence does not support universal bathing on general medical and surgical units as a routine practice, although it may be reasonable for patients with devices. Concerns about developing resistance to chlorhexidine are a further reason to target its use rather than apply it universally.

Implications for Practice

For a health system considering expanding chlorhexidine bathing from its intensive care units to general wards, the appraisal supports a targeted approach: bathing for patients with central lines and other invasive devices, with local monitoring of bloodstream infections and chlorhexidine resistance. It does not support replacing soap and water for all ward patients.

Limitations of the Appraisal

The appraisal focused on three key trials and did not include every observational study. A single appraiser rated the studies, which may introduce bias; a second appraiser rating a sample would strengthen it, and the ratings will be reviewed by the unit's clinical nurse specialist before the recommendation goes to the infection prevention committee.

Conclusion

Applying one instrument evenly to the key trials on chlorhexidine bathing shows that the evidence is strong for high-risk intensive care settings and weaker for general units. Separating level from quality, naming threats, criticizing supportive studies, and tracing conflicts to their causes produce a conclusion that is more precise than either "it works" or "it does not."

5

References

Climo, M. W., Yokoe, D. S., Warren, D. K., Perl, T. M., Bolon, M., Herwaldt, L. A., Weinstein, R. A., Sepkowitz, K. A., Jernigan, J. A., Sanogo, K., & Wong, E. S. (2013). Effect of daily chlorhexidine bathing on hospital-acquired infection. New England Journal of Medicine, 368(6), 533-542. https://doi.org/10.1056/nejmoa1113849

Dang, D., Dearholt, S. L., Bissett, K., Ascenzi, J., & Whalen, M. (2022). Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau International.

Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Heim, L., Gombosev, A., Avery, T. R., Haffenreffer, K., Shimelman, L., Hayden, M. K., Weinstein, R. A., Spencer-Smith, C., Kaganov, R. E., Murphy, M. V., Forehand, T., Lankiewicz, J., Coady, M. H., Portillo, L., ... Platt, R. (2019). Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): A cluster-randomised trial. The Lancet, 393(10177), 1205-1215. https://doi.org/10.1016/s0140-6736(18)32593-5

Noto, M. J., Domenico, H. J., Byrne, D. W., Talbot, T., Rice, T. W., Bernard, G. R., & Wheeler, A. P. (2015). Chlorhexidine bathing and health care-associated infections: A randomized clinical trial. JAMA, 313(4), 369-378. https://doi.org/10.1001/jama.2014.18400

Reading the NURS-FPX8006 Assessment 2 instructions

The instructions ask you to appraise the evidence retrieved for your clinical question using a recognized appraisal tool and evidence hierarchy. You select and justify an instrument, such as the Johns Hopkins model, summarize studies in a table, critique each study's methods and name specific threats to validity, rate level and quality separately, identify patterns and conflicts across studies and synthesize what the body of evidence supports. The appraisal should be applied consistently to every study. A table lets readers scan the set quickly, while the prose carries the critique. The synthesis prepares the recommendation in Assessment 3. Doctoral-level appraisal is critical of supportive studies as well as opposing ones.

Inside the NURS FPX 8006 Assessment 2 example

Instrument, table, critiques, pattern, standing. An instrument block names the appraisal tool and the leveling hierarchy and says why they fit this body of evidence. A table carries each study with design, sample, setting, outcome measured, level and quality rating, so a reader can scan the set without reading the prose. A critiques block writes out the substantive problems study by study, naming the threat rather than the category. A pattern block reports what the set does across studies: where findings agree, where they conflict, and whether the conflicts track design or population. A standing block states how strong the body of evidence is overall, in terms a committee would accept. Nothing is upgraded because it agrees with the writer.

NURS FPX 8006 Assessment 2 scoring guide: what Distinguished looks like

The scoring guide rates the instrument choice, the evidence table, the critiques, the synthesis and the writing. The instrument criterion reaches Distinguished when the choice is justified for the body of evidence. The table scores higher when it includes design, sample, setting, outcome, level and quality for every study. Critiques earn credit when they name specific threats, such as contamination between cluster arms, rather than labels like small sample. Separating level from quality shows understanding. The synthesis should explain conflicts rather than average them. Doctoral writing and APA 7 apply. The margin notes point to the conflict analysis, where differing results between trials are traced to their designs.

NURS FPX 8006 Assessment 2 help from the desk

The most common mistake is appraising studies inconsistently, with favored studies spared criticism. Another is treating level of evidence as quality, so a flawed randomized trial outranks a strong cohort study. Critiques often name categories of bias without the specific problem. Tables are incomplete. Conflicting findings are averaged instead of explained. Some papers skip the limits of the appraisal. Remember that the appraisal feeds a recommendation, so end with a synthesis a reader could act on, stating how confident the evidence allows anyone to be. A model appraisal of the evidence on your own question can be prepared for you at no charge.

Get a NURS FPX 8006 Assessment 2 example written to your instructions

Send the Assessment 2 instructions and the scoring guide from your NURS FPX 8006 courseroom, along with the studies your own appraisal covers. We write a custom example against those exact criteria and return it in 24 to 48 hours. The first custom sample is free, and appraising supportive studies as hard as contrary ones is what makes the whole set credible. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.

More NURS FPX 8006 papers and DNP samples

NURS FPX 8006 Assessment 2 questions, answered

Why separate level of evidence from quality?

Because they answer different questions. Level tells you what a design can establish in principle; quality tells you whether this particular study did it well. A badly conducted randomized trial can be less informative than a carefully done cohort study, and an appraisal that collapses the two will rank the weaker study higher purely on its design label.

How detailed does each critique need to be?

Detailed enough to name the specific threat. Small sample size is a category, not a critique; a sample of forty-one against a power calculation requiring ninety is a critique. The same applies to blinding, attrition and outcome measurement. Doctoral criteria reward the version where a reader could verify your judgment against the paper itself.

What do I do when studies disagree?

Look for what the disagreeing studies have in common. Conflicts usually track population, setting or how the outcome was measured rather than quality, and saying which turns a confusing evidence base into an informative one. A paper that reports the conflict and stops has done the appraisal but not the analysis the criteria ask for.

Where can I find a free NURS FPX 8006 Assessment 2 sample paper?

This page holds the full chlorhexidine bathing appraisal, with one instrument applied evenly, the evidence table, specific threats, conflict analysis and synthesis. A free custom appraisal is available.

Why separate level and quality of evidence in NURS FPX 8006 Assessment 2?

Level describes the design, such as a randomized trial; quality describes how well it was done. A poorly run trial can be weaker evidence than a well-run cohort study, so rating both gives a truer picture.